dc.contributor.authors |
Isik, Y; Palabiyik, O; Cegin, BM; Goktas, U; Kati, I; |
|
dc.date.accessioned |
2020-01-17T11:59:18Z |
|
dc.date.available |
2020-01-17T11:59:18Z |
|
dc.date.issued |
2016 |
|
dc.identifier.citation |
Isik, Y; Palabiyik, O; Cegin, BM; Goktas, U; Kati, I; (2016). Effects of Sugammadex and Neostigmine on Renal Biomarkers. MEDICAL SCIENCE MONITOR, 22, - |
|
dc.identifier.issn |
1643-3750 |
|
dc.identifier.uri |
https://hdl.handle.net/20.500.12619/7043 |
|
dc.description.abstract |
Conclusions: We believe that the use of more specific and sensitive new-generation markers like cystatin C to evaluate kidney function will provide a better understanding and interpretation of our results. Sugammadex has more tolerable effects on kidney function in patients than does neostigmine. However, when compared to preoperative values, there is a negative alteration of postoperative values. Neostigmine and sugammadex do not cause renal failure but they may affect kidney function. |
|
dc.language |
English |
|
dc.publisher |
INT SCIENTIFIC INFORMATION, INC |
|
dc.subject |
Research & Experimental Medicine |
|
dc.title |
Effects of Sugammadex and Neostigmine on Renal Biomarkers |
|
dc.type |
Article |
|
dc.identifier.volume |
22 |
|
dc.contributor.department |
Sakarya Üniversitesi/Tıp Fakültesi/Cerrahi Tıp Bilimleri Bölümü |
|
dc.contributor.saüauthor |
Palabıyık, Onur |
|
dc.relation.journal |
MEDICAL SCIENCE MONITOR |
|
dc.identifier.wos |
WOS:000371730300002 |
|
dc.contributor.author |
Yasemin Isik |
|
dc.contributor.author |
Palabıyık, Onur |
|
dc.contributor.author |
Bilal Muhammed Cegin |
|
dc.contributor.author |
Ugur Goktas |
|
dc.contributor.author |
Ismail Kati |
|